Lactobacillus plantarum and composition comprising same

Patent metadata

Field	Value
Publication number	US-10130666-B2
Application number	US-201514832214-A
Country	US
Kind code	B2
Filing date	Aug 21, 2015
Priority date	Jul 22, 2009
Publication date	Nov 20, 2018
Grant date	Nov 20, 2018

Abstract

The present invention provides Lactobacillus plantarum CJLP133 KCTC 11403BP, a composition for treating intestinal diseases comprising the lactic acid bacteria, and a composition for enhancing immunity comprising the lactic acid bacteria.

First claim

Having thus described the invention, there is claimed as new and desired to be secured by Letters Patent:

1. A bacterial composition, comprising:
Lactobacillus plantarum CJLP133 KCTC 11403BP; and
an effective amount of a lyophilization protecting agent,
wherein the bacterial composition is a freeze-dried composition.

2. The bacterial composition of claim 1 , wherein the cryoprotectant comprises one or more selected from the group consisting of skim milk and dextrin.

3. A pharmaceutical composition, comprising the bacterial composition of claim 1 and a suitable pharmaceutically acceptable carrier or additive.

4. The pharmaceutical composition of claim 3 , wherein a formulation of the pharmaceutical composition is selected from the group consisting of liquids, suspensions, powder, granules, tablets, capsules, pills and extracts.

5. A food composition, comprising the bacterial composition of claim 1 and a food.

6. The food composition of claim 5 , further comprising a sitologically acceptable excipient or additive.

7. A livestock feed composition, comprising the bacterial composition of claim 1 and a livestock feed.

8. A livestock feed additive, comprising the bacterial composition of claim 1 and an organic acid or a natural antioxidant.

9. A cosmetic, comprising the bacterial composition of claim 1 and a cosmetic excipient or additive.

10. The composition of claim 1 , suitable for use in treatment of a disease selected from atopic dermatitis, allergy, cancer and autoimmune disease.

11. The composition of claim 10 , wherein the disease is atopic dermatitis.

12. A method of treating atopic dermatitis, comprising the step of:
administering the bacterial composition of claim 1 to a subject suffering from atopic dermatitis.

13. The method of claim 12 , wherein the bacterial composition is administered orally.

14. The bacterial composition of claim 1 , further comprising a stabilizer.

15. The bacterial composition of claim 14 , wherein the stabilizer is selected from the group consisting of sodium carboxymethylcellulose, β-cyclodextrin, white wax and xanthan gum.

Assignees

• Cj Cheiljedang Corp

Inventors

• Kim Bong Joon
• Jung Heon Woong
• Hwang Se Hee
• Lee Jin Hee
• Lee Kang-Pyo
• Hwang Kwang Woo
• Won Tae Joon

Classifications

• A61P37/04

  Immunostimulants · CPC title

• A61P37/08

  Antiallergic agents (antiasthmatic agents A61P11/06; ophthalmic antiallergics A61P27/14) · CPC title

• A61P37/06

  Immunosuppressants, e.g. drugs for graft rejection · CPC title

• A61P35/00

  Antineoplastic agents · CPC title

• A61P43/00

  Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00 · CPC title